Audit of failure rate of Coartem to treat falciparum malaria at single fourteen day follow up

South African Family Practice

 
 
Field Value
 
Title Audit of failure rate of Coartem to treat falciparum malaria at single fourteen day follow up
 
Creator Vaughan Williams, C.H. La Cock, C. Henry, G.F.J. Ross, A.J.
 
Subject — falciparum malaria; lumefantrine; artemether
Description Objective: To assess the failure rate of the new first line treatment regime for uncomplicated falciparum malaria in KwaZulu-Natal of Coartem tablets (20mg aftemether and 120mg lumefantrine - Novartis South Africa (PTY Ltd.Design: A before-after study.Setting: Ndumo Clinic, Ingwavuma District, Kwazulu-Natal, South Africa, February 2001.Study Group: 67 patients presenting to Ndumo clinic with uncomplicated malaria, diagnosed by symptoms and positive immunochromographic test for plasmodium falciparum.Main outcome measures: All 58 follow-up slides obtained were negative. 8 patients failed to return, and 1 slide washed off. Only 43 smears were positive at day 0 of which 36 had follow-up smears.Conclusions: No resistance to Coartem was shown at day 4, and Coartem has been shown to be more effective at clearing falciparum malaria parasites than a previous regime of sulfadoxine/pyrimethamine with chlorine.
 
Publisher AOSIS
 
Contributor
Date 2002-03-30
 
Type info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion — —
Format application/pdf
Identifier 10.4102/safp.v25i3.2055
 
Source South African Family Practice; Vol 25, No 3 (2002); 5 2078-6204 2078-6190
 
Language eng
 
Relation
The following web links (URLs) may trigger a file download or direct you to an alternative webpage to gain access to a publication file format of the published article:

https://safpj.co.za/index.php/safpj/article/view/2055/2609
 
Coverage — — —
ADVERTISEMENT